Abstract Details

Title Cell Type-Specific Gene Expression Changes in the Blood of Multiple Sclerosis Patients in the Early Phase of Interferon-beta Treatment

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 289

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Michael Hecker, PhD (Universitatsmedizin Rostock, Klinik Fur Neurologie) PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Uwe Zettl	Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Zettl has received research support from BMBF(Government).

��ɫ��